Medical Science Liaison – Mid-Atlantic Region

Role Summary

We are building a best-in-class Field Medical organization within Beam Therapeutics. This Director or Associate Director level Medical Science Liaison will own a defined US territory with primary responsibility in sickle cell disease and shared accountability across the Beam pipeline (Alpha-1 antitrypsin deficiency and glycogen storage disease 1a). You will architect territory strategy, onboard priority treatment centers, engage KOLs and HCPs, generate actionable insights, and drive pre-commercial launch readiness in collaboration with cross-functional partners.

Responsibilities

• Develop and execute territory strategy: map treatment centers, referral networks, transplant/infusion sites, cell-collection capabilities, payers, and advocacy groups; prioritize accounts and set measurable objectives.
• Support treatment center onboarding: coordinate scientific and operational readiness aligned with SOPs, compliance, and patient journey requirements; partner with internal teams for qualification and activation.
• Build trusted relationships with KOLs and HCPs: deliver fair-balanced, evidence-based education on rare diseases, cell and gene therapy science, and Beam’s platform; foster advocacy and awareness.
• Educate stakeholders on disease state, therapeutic landscape, and company platform to drive awareness and credibility in the rare disease and CGT space.
• Generate high-quality insights from field interactions: synthesize trends and communicate actionable recommendations to Medical Affairs leadership and cross-functional partners.
• Collaborate on pre-launch planning: align with Medical Strategy, Publications, Medical Information, Value & Evidence, and Medical Operations to ensure scientific messaging, data dissemination, and field tools are ready for first commercial launch.
• Support clinical research activities: identify potential sites, assist with feasibility assessments, and promote best practices for enrollment and retention while maintaining medical/scientific independence.
• Partner cross-functionally with Commercial, Market Access, and Clinical teams while preserving medical independence; coordinate account plans to ensure seamless patient access and avoid duplication.
• Represent the company at congresses and external scientific meetings: plan and execute presence, engage in meaningful scientific exchanges, and follow up to strengthen visibility and credibility.
• Provide education and resources to treatment centers on operational readiness for advanced therapies, including apheresis and cell-handling processes.
• Serve as a trusted resource for compliance and ethical standards: ensure all interactions and materials meet company policies, regulatory requirements, and industry code.
• Maintain operational excellence: document activities and insights in CRM, monitor KPIs, and continuously improve processes, content, and tools.
• Prepare and deliver training for internal teams and external stakeholders on rare disease management and CGT fundamentals to support launch readiness.
• Act as a scientific ambassador for the company: articulate the value of the platform and pipeline to diverse audiences including clinicians, researchers, and advocacy groups.
• Monitor evolving evidence and the competitive landscape in rare disease and CGT; share updates internally to inform strategy and decision-making.

Qualifications

• Advanced scientific degree (PharmD, PhD, MD, or equivalent).
• Approximately 10+ years of industry experience in Medical Affairs with significant Field Medical tenure.
• Rare disease expertise required; hematology strongly preferred with emphasis on SCD.
• Small biotech experience preferred; demonstrated impact in resource-constrained settings.
• Launch experience (pre-approval to post-launch), ideally in CGT or complex specialty (buy‑and‑bill) environment.
• Proven territory management and account planning capability across complex ecosystems (academic centers, community networks, payers, advocacy groups).
• Independent, proactive operator with strong ownership; cross-functional collaboration with Clinical, Regulatory, Commercial, Medical Operations, and Publications while maintaining medical/scientific integrity.
• Outstanding communication skills; ability to translate complex science into a clear, credible narrative.
• Analytical strength for insight collection, synthesis, and actionable recommendations.

Additional Requirements

• Travel up to approximately 60% across the assigned territory.